[Protease inhibitors are effective not only in AIDS].
Wehr
A
A
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy; D056657:Cathepsin K; D002403:Cathepsins / Q000037:antagonists & inhibitors; D004151:Dipeptides / Q000627:therapeutic use; D006801:Humans; D009362:Neoplasm Metastasis / Q000517:prevention & control; D010024:Osteoporosis / Q000188:drug therapy; D011480:Protease Inhibitors / Q000627:therapeutic use*; D015842:Serine Proteinase Inhibitors / Q000627:therapeutic use; D019714:Tissue Inhibitor of Metalloproteinases / Q000627:therapeutic use
D000970:Antineoplastic Agents; D004151:Dipeptides; C094700:N-(1-hydroxy-2-naphthoyl)arginyl-prolinamide; D011480:Protease Inhibitors; D015842:Serine Proteinase Inhibitors; D019714:Tissue Inhibitor of Metalloproteinases; D002403:Cathepsins; C534130:CTSK protein, human; D056657:Cathepsin K
Proteasehemmer--nicht nur bei AIDS wirksam.